Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis

NCT01712360 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Tinea Pedis
Tinea Cruris

Interventions

DRUG: NAFT500 (pediatric)
DRUG: NAFT600 (pediatric)
DRUG: NAFT500 (adult)
DRUG: NAFT600 (adult)

Sponsor

Merz North America, Inc.